Therapeutic Vaccines Market Poised to Grow at a CAGR of 7.3% by 2024

Therapeutic Vaccines Market Poised to Grow at a CAGR of 7.3% by 2024


Infinium Global Research has added a new report on Therapeutic Vaccines Market. The report presents analysis of global as well as regional markets of therapeutic vaccines market over the period of 2016 to 2024.

 

Therapeutic vaccines aren't used for prevention. Instead, they're used as a method of treatment. Therapeutic Vaccines are used to stimulate the immune system to target an infection or a type of diseased cell - such as a cancer cell. complications of a chronic diseases such as Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Hepatitis and Varicella Dengue. It is accomplished by controlling the presence of viruses in the blood and reducing the viral set-point in infected people. According to U.S. Food and Drug Administration, promising results from clinical trials recently led to the approval of the first therapeutic cancer vaccine.According to World Health Organization "Allergen immunotherapy Therapeutic vaccines for allergic diseases." The historical term allergen extract was changed to allergen vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers.

 

 The major driving factor such as increasing occurrence of cancer, cardiovascular diseases, HIV infection and various chronic diseases are boosting the therapeutic vaccines market. In addition, Increase in funding’s from government for vaccine development and growing awareness among people for severe disease are the key factors escalating the growth of Therapeutic Vaccines Market. However, high cost associated with treatment is expected to hinder the growth of Therapeutic Vaccines Market. Moreover, various pharmaceutical players in this market are extensively researching on the research & Development activities to develop novel vaccines for several diseases that may create growth opportunities for Therapeutic Vaccines Market in the near future.

 

Among the geographies, North America is the leading contributor in the Therapeutic Vaccines Market. The U.S has the largest market share in the North America region. Developed medical and healthcare infrastructure and increasing funding for research and development activities are the few factors augmenting the growth in the North America region. On the other hand, Asia Pacific region is anticipated to be the fastest growing market in upcoming year owing to the increasing prevalence of various diseases, rising disposable income and rapidly growing aging population. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global therapeutic vaccines market but also make strategic decisions to capture the most lucrative markets in the near future.

 

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

 

Get 15% discount for early purchase of global therapeutic vaccines market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/1486

 

The recent report identified that North America dominated the global therapeutic vaccines market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the therapeutic vaccines market worldwide.

 

The report segments the global therapeutic vaccines market on the basis of Vaccines Type, Disease Indication, Administration and End User.

 

Global Therapeutic Vaccines Market by Vaccines Type

·         Auto Immune Diseases Vaccines

·         Neurological Disease Vaccines

·         Chronic Disease Vaccines

·         Infectious Diseases Vaccines

 

Global Therapeutic Vaccines Market by Disease Indication

·         Pneumococcal Disease 

·         DTP 

·         Influenza 

·         Human Papilloma Virus 

·         Meningococcal Disease 

·         Polio 

·         Hepatitis 

·         MMR 

·         Varicella

·          Dengue 

 

Global Therapeutic Vaccines Market by Administration

·         Intramuscular And Subcutaneous Administration 

·         Oral Administration 

·         Other Routes Of Administration

 

Global Therapeutic Vaccines Market by End User

·         Pediatrics 

·         Adults

 

Companies Profiled in the Report

·         Pfizer, Inc. 

·         Glaxosmithkline PLC. 

·         Merck & Co., Inc. 

·         Sanofi Pasteur SA 

·         CSL Limited 

·         Emergent Biosolutions, Inc. 

·         Johnson & Johnson 

·         MedImmune

·         Astellas Pharma, Inc. 

·         Serum Institute of India

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.


© 2024. Infinium Global Research LLP. All Rights Reserved.